Trustmark (TRMK) Stock Chart & Stock Price History → Why Big Pharma is Investing Billions in This Biotech (From Behind the Markets) (Ad) Free TRMK Stock Alerts $30.05 +0.23 (+0.77%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Trustmark Stock Price Performance5 Day Performance+12.34%1 Month Performance+7.09%3 Month Performance+6.75%6 Month Performance+54.34%Year-To-Date Performance+7.78%1 Year Performance+25.47% Receive TRMK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trustmark and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy TRMK Stock Chart for Saturday, April, 27, 2024 TRMK Chart by TradingView Trustmark Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$29.82$30.05+0.77%$30.21$29.80309,846 shs$1.84 billion04/25/2024$29.36$29.82+1.57%$30.09$29.36739,757 shs$1.82 billion04/24/2024$27.55$29.36+6.57%$29.84$28.40724,854 shs$1.80 billion04/23/2024$26.75$27.55+2.99%$27.83$26.72274,462 shs$1.69 billion04/22/2024$26.73$26.75+0.07%$27.14$26.65263,792 shs$1.64 billion04/19/2024$25.73$26.73+3.89%$26.79$25.62294,093 shs$1.64 billion Get the Latest News and Ratings for TRMK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trustmark and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$25.46$25.73+1.06%$25.95$25.44349,618 shs$1.57 billion04/17/2024$25.63$25.46-0.66%$26.01$25.41208,826 shs$1.56 billion04/16/2024$26.04$25.63-1.57%$26.05$25.63309,432 shs$1.57 billion04/15/2024$26.20$26.04-0.61%$26.48$25.76325,759 shs$1.59 billion04/12/2024$26.43$26.20-0.87%$26.41$26.09236,670 shs$1.60 billion04/11/2024$26.50$26.43-0.26%$26.74$26.22237,657 shs$1.62 billion04/10/2024$27.48$26.50-3.57%$26.98$26.10356,280 shs$1.62 billion04/09/2024$27.33$27.48+0.55%$27.69$27.38186,328 shs$1.68 billion04/08/2024$27.14$27.33+0.70%$27.54$27.24108,491 shs$1.67 billion04/05/2024$26.90$27.14+0.89%$27.25$26.77221,227 shs$1.66 billion04/04/2024$26.68$26.90+0.82%$27.64$26.80315,014 shs$1.65 billion04/03/2024$26.92$26.68-0.89%$27.02$26.62285,898 shs$1.63 billion04/02/2024$27.51$26.92-2.14%$27.34$26.76309,711 shs$1.65 billion04/01/2024$28.11$27.51-2.13%$28.07$27.43220,060 shs$1.68 billion03/29/2024$28.11$28.11$28.57$27.92465,867 shs$1.72 billion03/28/2024$28.06$28.11+0.18%$28.57$27.92386,767 shs$1.72 billion03/27/2024$27.25$28.06+2.97%$28.09$27.49247,025 shs$1.72 billion03/26/2024$26.92$27.25+1.23%$27.37$27.06291,726 shs$1.67 billion03/25/2024$26.42$26.92+1.89%$27.33$26.46599,259 shs$1.65 billion03/22/2024$26.95$26.42-1.97%$27.05$26.38141,390 shs$1.62 billion03/21/2024$26.67$26.95+1.05%$27.19$26.77229,436 shs$1.65 billion03/20/2024$25.82$26.67+3.29%$26.92$25.64200,978 shs$1.63 billion03/19/2024$25.65$25.82+0.66%$26.07$25.60156,640 shs$1.58 billion03/18/2024$25.92$25.65-1.04%$26.08$25.53276,443 shs$1.57 billion03/15/2024$25.52$25.92+1.57%$26.00$25.39764,998 shs$1.58 billion03/14/2024$26.06$25.52-2.07%$25.96$25.37315,138 shs$1.56 billion03/13/2024$26.15$26.06-0.34%$26.38$25.86171,797 shs$1.59 billion03/12/2024$26.94$26.15-2.93%$26.80$26.14215,300 shs$1.60 billion03/11/2024$27.01$26.94-0.26%$27.04$26.70147,039 shs$1.65 billion03/08/2024$27.13$27.01-0.44%$27.58$27.00160,918 shs$1.65 billion03/07/2024$27.01$27.13+0.44%$27.57$26.87200,964 shs$1.66 billion03/06/2024$26.96$27.01+0.19%$27.46$26.39204,028 shs$1.65 billion03/05/2024$25.99$26.96+3.73%$26.96$25.83307,361 shs$1.65 billion03/04/2024$26.54$25.99-2.07%$26.90$25.92355,164 shs$1.59 billionWhy Big Pharma is Investing Billions in This Biotech (Ad)If you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>>03/01/2024$26.86$26.54-1.19%$26.83$26.11249,882 shs$1.62 billion02/29/2024$26.59$26.86+1.02%$27.37$26.65255,405 shs$1.64 billion02/28/2024$26.56$26.59+0.11%$26.77$26.22240,632 shs$1.62 billion02/27/2024$26.39$26.56+0.64%$26.73$26.44203,140 shs$1.62 billion02/26/2024$26.88$26.39-1.82%$26.97$26.30193,193 shs$1.61 billion02/23/2024$26.80$26.88+0.30%$27.16$26.68131,884 shs$1.64 billion02/22/2024$26.80$26.80$26.89$26.54221,258 shs$1.64 billion02/21/2024$27.14$26.80-1.25%$27.06$26.65196,251 shs$1.64 billion02/20/2024$27.17$27.14-0.11%$27.40$26.82295,058 shs$1.66 billion02/19/2024$27.17$27.17$27.51$27.06206,600 shs$1.66 billion02/16/2024$27.58$27.17-1.49%$27.51$27.06206,668 shs$1.66 billion02/15/2024$26.70$27.58+3.30%$27.74$26.69201,167 shs$1.68 billion02/14/2024$26.38$26.70+1.21%$26.87$26.18232,702 shs$1.63 billion02/13/2024$27.47$26.38-3.97%$26.74$25.82341,740 shs$1.61 billion02/12/2024$27.12$27.47+1.29%$27.90$27.17273,264 shs$1.68 billion02/09/2024$26.63$27.12+1.84%$27.15$26.30181,254 shs$1.66 billion02/08/2024$26.56$26.63+0.26%$26.83$26.39182,511 shs$1.63 billion02/07/2024$26.71$26.56-0.56%$26.88$25.91246,418 shs$1.62 billion02/06/2024$26.95$26.71-0.89%$27.19$26.49172,253 shs$1.63 billion02/05/2024$27.15$26.95-0.74%$27.14$26.62239,451 shs$1.65 billion02/02/2024$27.15$27.15$27.54$26.53291,019 shs$1.66 billion02/01/2024$26.99$27.15+0.59%$27.45$26.12377,697 shs$1.66 billion01/31/2024$28.22$26.99-4.36%$28.01$26.83339,839 shs$1.65 billion01/30/2024$28.55$28.22-1.16%$28.55$28.17213,227 shs$1.72 billion01/29/2024$28.15$28.55+1.42%$28.57$28.07280,563 shs$1.74 billion01/26/2024$28.03$28.15+0.43%$28.58$28.01234,365 shs$1.72 billion Related Companies: NBT Bancorp Stock Chart WesBanco Stock Chart City Stock Chart Bancorp Stock Chart First Commonwealth Financial Stock Chart Hope Bancorp Stock Chart National Bank Stock Chart Westamerica Bancorporation Stock Chart First Merchants Stock Chart First Financial Bancorp. Stock Chart Receive TRMK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trustmark and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRMK) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market InsidersThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trustmark Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.